NUP210 and Cirrhosis: The differences of transplant-free survival rates, as well as adverse outcome-free survival rates between anti-gp210 positive PBC patients with cirrhosis and anti-gp210 negative PBC patients with cirrhosis at baseline were statistically significant (P values were all <0.05) (Figures 4C, D).